These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the safety of short-acting nifedipine in children with hypertension. Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132 [TBL] [Abstract][Full Text] [Related]
5. Another report of adverse reactions to immediate-release nifedipine. Fami MJ; Ho NT; Mason CM Pharmacotherapy; 1998; 18(5):1133-5. PubMed ID: 9758326 [TBL] [Abstract][Full Text] [Related]
6. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? Grossman E; Messerli FH; Grodzicki T; Kowey P JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992 [TBL] [Abstract][Full Text] [Related]
7. Safety of calcium antagonists: more ACTION. Messerli FH; Staessen JA Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803 [No Abstract] [Full Text] [Related]
8. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?]. Martsevich SIu Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608 [TBL] [Abstract][Full Text] [Related]
9. A moratorium should be placed on the use of short-acting nifedipine for hypertensive crises. Truttmann AC; Zehnder-Schlapbach S; Bianchetti MG Pediatr Nephrol; 1998 Apr; 12(3):259. PubMed ID: 9630050 [No Abstract] [Full Text] [Related]
10. Calcium channel blockers in the dock: innocent or guilty? Mackay JA; Sever PS J Hum Hypertens; 1996 May; 10(5):277-80. PubMed ID: 8817399 [TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists: when the content does not justify the headline. Jackson G Br J Clin Pract; 1995; 49(6):283-4. PubMed ID: 8554947 [No Abstract] [Full Text] [Related]
14. [Clinical features and up-to-date therapy of hypertensive emergencies]. Meyer FP Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498 [No Abstract] [Full Text] [Related]
15. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Opie LH; Yusuf S; Kübler W Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332 [TBL] [Abstract][Full Text] [Related]
16. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension]. Głuszek J; Pawlaczyk-Gabriel K Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678 [TBL] [Abstract][Full Text] [Related]
17. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]